Figure 8.
ID93+EmT4™ provides prophylactic pulmonary protection against 2 M.tb isolates at 4 wk post-challenge. Cohorts of mice receiving saline, BCG, EmT4™ or ID93+EmT4™ vaccination regimens were then challenged with a LDA of either M.tb HN878 (A-B) or M.tb H37Rv (C, D) 4 wk after the third immunization. Bacterial burden was assessed by colony forming units (CFU) in lung (A, C) and spleen (B, D) organ homogenates 4 wk after challenge. Bars show the mean ± SEM and dots represent individual mice (n = 5-7/group). Asterisks indicate statistical significance compared to the saline group, where *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 using 1-way ANOVA with Dunnett’s multiple comparisons test.

ID93+EmT4™ provides prophylactic pulmonary protection against 2 M.tb isolates at 4 wk post-challenge. Cohorts of mice receiving saline, BCG, EmT4™ or ID93+EmT4™ vaccination regimens were then challenged with a LDA of either M.tb HN878 (A-B) or M.tb H37Rv (C, D) 4 wk after the third immunization. Bacterial burden was assessed by colony forming units (CFU) in lung (A, C) and spleen (B, D) organ homogenates 4 wk after challenge. Bars show the mean ± SEM and dots represent individual mice (n = 5-7/group). Asterisks indicate statistical significance compared to the saline group, where *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 using 1-way ANOVA with Dunnett’s multiple comparisons test.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close